Other OTC - Delayed Quote USD

Hemagen Diagnostics, Inc. (HMGN)

0.0000 0.0000 (0.00%)
At close: December 6 at 1:25 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
Total Revenue
4,042.0940
Cost of Revenue
2,428.6490
Gross Profit
1,613.4450
Operating Expense
2,051.3590
Operating Income
-437.9140
Net Non Operating Interest Income Expense
-469.1740
Other Income Expense
-0.2270
Pretax Income
-907.3150
Net Income Common Stockholders
-907.3150
Diluted NI Available to Com Stockholders
-907.3150
Basic EPS
-0.06
Diluted EPS
-0.06
Basic Average Shares
15,496.2370
Diluted Average Shares
15,496.2370
Total Operating Income as Reported
-437.9140
Total Expenses
4,480.0080
Net Income from Continuing & Discontinued Operation
-907.3150
Normalized Income
-907.0880
Interest Expense
469.1740
Net Interest Income
-469.1740
EBIT
-438.1410
EBITDA
-273.8910
Reconciled Cost of Revenue
2,428.6490
Reconciled Depreciation
164.2500
Net Income from Continuing Operation Net Minority Interest
-907.3150
Total Unusual Items Excluding Goodwill
-0.2270
Total Unusual Items
-0.2270
Normalized EBITDA
-273.6640
-
Yahoo Finance Plus Essential access required. Unlock Access